2025 Speaker Faculty

Alexandra Miller

Attending

NYU Langone Health

ANNE DAGALLIER

Director Business Development, Global Lead of Oncology

Servier

Atique Ahmed

Professor

Northwestern University

Carla Bauer

Director, Oncology Search and Evaluation, Business Development & Licensing

Merck & Co

Carlo Russo

CMO - Chief Medical Officer& Head of Development

Genenta Science

Chris Pak

President & Chief executive officer

Molecular Targeting Technologies

Christophe Queva

Chief Scientific Officer

Ovid Therapeutics Inc.

Daniel Lee

Investor

Blackstone

Daniel Yokell

Vice President - Theranostic & NeuroOncology

Telix Pharmaceuticals

David Andrews

Chief Medical Officer

Imvax Inc.

Ditte Primdahl

MD

Northwestern University

Donald J. Davidson

Chief Executive Officer & Founder

Creative BioTherapeutics

Dr. Vijay Modur

Chief Medical Officer

BPGBio Inc.

Erik Sulman

Professor and Vice Chair of Research

Department of Radiation Oncology

Jeff Knipstein

Medical Director

Servier

Jessica Foley

CSO

Focused Ultrasound Foundation

Johannes vom Berg

Chief Scientific Officer

InCephalo

Kirk Tanner

SVP Clinical Development

Autem Therapeutics

Lawrence Lamb

Executive VP, Chief Scientific Officer & Co-Founder

IN8Bio

Martha Neagu

Senior Medical Director

Abbvie

Noel Brown

Managing Director, Head of U.S. Biotechnology Investment Banking

RBC Capital Markets

Patrick Wen

Director, Center For Neuro-Oncology

Dana-Farber / Harvard Cancer Center

Priya Kumthekar

Neuro Oncologist

Northwestern University

Stephen Bagley

Section Chief, Neuro-Oncology

University of Pennsylvania

Stephen Marcus

Chief Executive Officer

Cantex Pharmaceuticals

Steven Rosenfeld

Professor

Mayo Clinic

Vanaja Konduri

VP Research&Development

Diakonos Oncology

Yash Thukral

Founding Partner

White Lion Capital LLC

REGISTER
PARTNER
EVENT GUIDE